Cadence’s RPM Transforms Healthcare Delivery for Patients and Providers

 

As healthcare continues to evolve, the need for efficient management of chronic diseases becomes more pressing. Remote patient monitoring (RPM) emerges as a crucial innovation in this landscape, offering a solution to the rising number of chronic disease cases and the subsequent strain on healthcare systems. A 2023 study found that 60% of American adults have at least one chronic condition, highlighting the urgency for effective management solutions.

Can remote patient monitoring revolutionize chronic disease management, and what are the tangible benefits for patients and healthcare providers?

In the latest episode of I Don’t Care with Dr. Kevin Stevenson, host Dr. Kevin Stevenson engages in a timely discussion with Dr. Ted Feldman, Chief Medical Officer of Cadence. The episode delves into the capabilities and impact of Cadence’s RPM technology, which partners with hospitals and health systems to enhance patient outcomes and alleviate clinician workload through advanced practice provider-led clinical care teams.

Key Points of Discussion:

  • Seamless Integration: Cadence’s cellular-enabled RPM technology simplifies patient enrollment and data collection without the need for additional devices or applications.
  • Effective Communication: Integration with major electronic medical records (EMRs) ensures that patient data is accessible to healthcare providers, enhancing treatment continuity and decision-making.
  • Care Delivery Teams: Cadence attaches care delivery teams to RPM data, ensuring that patients receive guideline-directed medical therapy (GDMT) and ongoing monitoring, ultimately reducing hospital readmissions and improving clinical outcomes.

Dr. Ted Feldman has over 37 years of experience in interventional cardiology. His career includes pioneering work in percutaneous coronary interventions and significant contributions to clinical trials for chronic disease treatments. As the Chief Medical Officer of Cadence, Dr. Feldman leverages his extensive background to advance the use of technology in chronic disease management.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…